Can a weight loss and diabetes drug treat long COVID?

Scripps Research announced a new clinical trial Thursday that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID, the debilitating chronic condition diagnosed in an estimated 20 million Americans and about 400 million people worldwide.
Developed to help people with type 2 diabetes control their blood sugar levels, these GLP-1 medications have generated billions of dollars in revenue for their ability to slow the pace of digestion and